missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Recombinant Human Clusterin Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Brand:  R&D Systems™ 2937-HS-050

Product Code. 18391318

  • £418.00 / 50µg

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

The Recombinant Human Clusterin Protein is derived from NS0. The Recombinant Human Clusterin Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

Lyophilized from a 0.2μm filtered solution in PBS.
26.7 kDa ( alpha chain) and 24.2 kDa (beta chain)
50 μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Unconjugated
90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
1191
Clusterin
Mouse myeloma cell line,NS0-derived human Clusterin protein Asp23-Arg227 (beta) & Ser228-Glu449 (alpha) with a C-terminal 6-His tag
Disulfide-linked heterodimer
Recombinant
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.